AMP-activated Protein Kinase α2 Subunit Is Required for the Preservation of Hepatic Insulin Sensitivity by n-3 Polyunsaturated Fatty Acids
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The induction of obesity, dyslipidemia, and insulin resistance by high-fat diet in rodents can be prevented by n-3 long-chain polyunsaturated fatty acids (LC-PUFAs). We tested a hypothesis whether AMP-activated protein kinase (AMPK) has a role in the beneficial effects of n-3 LC-PUFAs. RESEARCH DESIGN AND METHODS: Mice with a whole-body deletion of the α2 catalytic subunit of AMPK (AMPKα2(-/-)) and their wild-type littermates were fed on either a low-fat chow, or a corn oil-based high-fat diet (cHF), or a cHF diet with 15% lipids replaced by n-3 LC-PUFA concentrate (cHF+F). RESULTS: Feeding a cHF diet induced obesity, dyslipidemia, hepatic steatosis, and whole-body insulin resistance in mice of both genotypes. Although cHF+F feeding increased hepatic AMPKα2 activity, the body weight gain, dyslipidemia, and the accumulation of hepatic triglycerides were prevented by the cHF+F diet to a similar degree in both AMPKα2(-/-) and wild-type mice in ad libitum-fed state. However, preservation of hepatic insulin sensitivity by n-3 LC-PUFAs required functional AMPKα2 and correlated with the induction of adiponectin and reduction in liver diacylglycerol content. Under hyperinsulinemic-euglycemic conditions, AMPKα2 was essential for preserving low levels of both hepatic and plasma triglycerides, as well as plasma free fatty acids, in response to the n-3 LC-PUFA treatment. CONCLUSIONS: Our results show that n-3 LC-PUFAs prevent hepatic insulin resistance in an AMPKα2-dependent manner and support the role of adiponectin and hepatic diacylglycerols in the regulation of insulin sensitivity. AMPKα2 is also essential for hypolipidemic and antisteatotic effects of n-3 LC-PUFA under insulin-stimulated conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, knockout of AMPK subunit alpha 2 abrogates the improvement in hepatic insulin sensitivity by omega-3 PUFAs during a high fat diet despite studies observing little interaction between omega-3 PUFAs and AMPK [142].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 15×
“When insulin and glucose levels are high, such as during hyperinsulinemic-euglycemic clamp, wild-type mice fed n-3 LC-PUFAs exhibit improved hepatic insulin sensitivity and decreased plasma levels of NEFAs as compared with high-fat diet-fed controls.”
BackgroundInfluentialKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“energy levels, namely, the partitioning between lipid oxidation and lipogenesis (29,30).”
BackgroundLKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
The AMP-activated protein kinase cascade – a unifying system for energy control
Carling, D. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.11.005 · Cited by 1,112 · cited 1×
“AMPK is a heterotrimeric protein consisting of a catalytic -subunit and regulatory - and -subunits, with multiple isoforms identified for each subunit [ 1, 2, 1, 2, 1, 2, and 3; reviewed in ref (25)].”
BackgroundAMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,026 · cited 2×
“Four-month-old whole-body AMPK 2 / mice (29) backcrossed to C57BL/6J mice for nine generations, and wild-type littermate controls were fed on either Chow, cHF, or cHF F diet for nine weeks.”
BackgroundMethodForetz, M., Guichard, C., Ferré, P., & Foufelle, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12737 · Cited by 747 · cited 1×
“Hepatocytes were isolated from livers of fed mice by a modification of the collagenase method (34) and seeded at a density of 0.”
MethodFish Oil Prevents Insulin Resistance Induced by High-Fat Feeding in Rats
Storlien, L. H., Kraegen, E. W., Chisholm, D. J., Ford, G. L., Bruce, D. G., & Pascoe, W. S. (1987) · Science · doi:10.1126/science.3303333 · Cited by 650 · cited 2×
“Previous animal studies demonstrated that n-3 LC-PUFAs could counteract the development of both hepatic steatosis (8,18,36,37) and hepatic insulin resistance (8,9,16), while suppressing lipogenesis and augmenting lipid catabolism in the liver (8,13,19,21).”
BackgroundNawrocki, A. R., Rajala, M. W., Tomas, E., Pajvani, U. B., Saha, A. K., Trumbauer, M. E., Pang, Z., Chen, A. S., Ruderman, N. B., Chen, H., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505311200 · Cited by 639 · cited 1×
“nes, whereas mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to these compounds (48).”
BackgroundCharacterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding
CHEUNG, P. C. F., SALT, I. P., DAVIES, S. P., HARDIE, D. G., & CARLING, D. (2000) · Biochemical Journal · doi:10.1042/bj3460659 · Cited by 637 · cited 1×
“AMPK 1 and AMPK 2 contribute equally to total AMPK activity in the liver (50).”
BackgroundGonzález-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López-Parra, M., Arroyo, V., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125674 · Cited by 555
Uyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 529 · cited 1×
“Previous animal studies demonstrated that n-3 LC-PUFAs could counteract the development of both hepatic steatosis (8,18,36,37) and hepatic insulin resistance (8,9,16), while suppressing lipogenesis and augmenting lipid catabolism in the liver (8,13,19,21).”
The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
Viollet, B., Andreelli, F., Jørgensen, S. B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16567 · Cited by 499 · cited 4×
“Thus, in accordance with the previous study (26), the results of clamp studies suggested impairment of insulin sensitivity in response to whole-body ablation of AMPK 2 in Chow-fed mice.”
BackgroundMethodResultInfluentialSelf-citationFlachs, P., Horakova, O., Brauner, P., Rossmeisl, M., Pecina, P., Franssen-van Hal, N., Ruzickova, J., Sponarova, J., Drahota, Z., Vlcek, C., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1944-7 · Cited by 388 · cited 1×
“The hypolipidemic and antiobesity effects of n-3 LCPUFAs depend on both the suppression of lipogenesis and the increase in fatty acid oxidation in several tissues, including the liver (13,14), adipose tissue (6), and intestine (15).”
BackgroundSelf-citationForetz, M., Ancellin, N., Andreelli, F., Saintillan, Y., Grondin, P., Kahn, A., Thorens, B., Vaulont, S., & Viollet, B. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1331 · Cited by 388 · cited 1×
“Experiments using whole-body AMPK 2 null [AMPK 2 / ; ref (26)] mice showed the importance of the AMPK 2 subunit for whole-body insulin action, while liver-specific AMPK 2 knockout mice (27) as well as adenovirus-mediated activation of AMPK 2 in the liver (28) implicated the hepatic AMPK 2 isoform in the suppression of…”
MethodSelf-citationPolyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet
Flachs, P., Mohamed-Ali, V., Horakova, O., Rossmeisl, M., Hosseinzadeh-Attar, M. J., Hensler, M., Ruzickova, J., & Kopecky, J. (2006) · Diabetologia · doi:10.1007/s00125-005-0053-y · Cited by 357 · cited 1×
“On the other hand, induction of adiponectin by n-3 LC-PUFAs [results of this study and refs (46,47)] could be involved, because adiponectin activates AMPK in both the liver and skeletal muscle (35).”
BackgroundSelf-citationFatty Acid Regulation of Gene Transcription
Jump, D. B. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490278341 · Cited by 356 · cited 2×
“It is generally accepted that 1) diacylglycerols rather than triglycerides or ceramides mediate hepatic insulin resistance in mice fed a high-fat diet (19,38,39), 2) diacylglycerol-induced insulin resistance depends on activation of protein kinase C, and 3) that polyunsaturated diacylglycerols in particular are better…”
BackgroundStansbie, D., Brownsey, R. W., Crettaz, M., & Denton, R. M. (1976) · Biochemical Journal · doi:10.1042/bj1600413 · Cited by 352
Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults
Couet, C., Delarue, J., Ritz, P., Antoine, J.-M., & Lamisse, F. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800451 · Cited by 344 · cited 1×
“Studies of obese humans have also demonstrated a reduction in adiposity after n-3 LC-PUFA supplementation (3,4).”
Backgroundn-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review
Nettleton, J. A., & Katz, R. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.11.029 · Cited by 339
Ruzickova, J., Rossmeisl, M., Prazak, T., Flachs, P., Sponarova, J., Vecka, M., Tvrzicka, E., Bryhn, M., & Kopecky, J. (2004) · Lipids · doi:10.1007/s11745-004-1345-9 · Cited by 327
Self-citationAnti-lipolytic Action of AMP-activated Protein Kinase in Rodent Adipocytes
Daval, M., Diot-Dupuy, F., Bazin, R., Hainault, I., Viollet, B., Vaulont, S., Hajduch, E., Ferré, P., & Foufelle, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414222200 · Cited by 324 · cited 1×
“That plasma NEFA levels under clamp conditions were reduced only in wild-type but not in AMPK 2 / mice fed n-3 LC-PUFAs may reflect a role of AMPK 2 in muscle lipid uptake mediated by lipoprotein lipase (41), as well as the antilipolytic effect of AMPK in adipose tissue, documented for AMPK 1 (42).”
BackgroundSelf-citationDentin, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25256 · Cited by 315 · cited 2×
“In addition, no effect on AMPK activity in either cultured hepatocytes (21) or embryonic kidney cells (not shown) of n-3 LC-PUFAs added to the cell culture medium could be detected.”
BackgroundMori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., Watts, G. F., & Beilin, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.5.817 · Cited by 296 · cited 2×
“However, in diabetic patients, n-3 LC-PUFAs appear to have little effect on glycemic control (3,11,12).”
BackgroundHeterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet
Burcelin, R., Crivelli, V., Dacosta, A., Roy-Tirelli, A., & Thorens, B. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00332.2001 · Cited by 292 · cited 2×
“Five days before the experiment, an indwelling catheter was placed into the left femoral vein under anesthesia (33).”
MethodItoh, M., Suganami, T., Satoh, N., Tanimoto-Koyama, K., Yuan, X., Tanaka, M., Kawano, H., Yano, T., Aoe, S., Takeya, M., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.106.136853 · Cited by 290 · cited 1×
“On the other hand, induction of adiponectin by n-3 LC-PUFAs [results of this study and refs (46,47)] could be involved, because adiponectin activates AMPK in both the liver and skeletal muscle (35).”
BackgroundFlachs, P., Rossmeisl, M., Bryhn, M., & Kopecky, J. (2009) · Clinical Science · doi:10.1042/cs20070456 · Cited by 286 · cited 1×
“Diabetes 59:2737–2746, 2010 Naturally occurring n-3 long-chain polyunsaturated fatty acids (LC-PUFAs)—namely, eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)—which are abundant in sea fish, act as hypolipidemics, reduce cardiac events, and decrease the progression of atherosclerosis [reviewed in ref…”
BackgroundSelf-citationHigh-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils
Ikemoto, S., Takahashi, M., Tsunoda, N., Maruyama, K., Itakura, H., & Ezaki, O. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90185-7 · Cited by 276
Neschen, S., Morino, K., Rossbacher, J. C., Pongratz, R. L., Cline, G. W., Sono, S., Gillum, M., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0985 · Cited by 275
Andreelli, F., Foretz, M., Knauf, C., Cani, P. D., Perrin, C., Iglesias, M. A., Pillot, B., Bado, A., Tronche, F., Mithieux, G., et al. (2006) · Endocrinology · doi:10.1210/en.2005-0898 · Cited by 237 · cited 3×
“In mice with liver-specific ablation of AMPK 2 (27), hepatic AMPK 2 was essential for suppressing hepatic glucose production and maintaining fasting blood glucose levels; however, the absence of AMPK 2 did not affect inhibitory action of insulin on hepatic glucose production.”
BackgroundMethodSelf-citationNeschen, S., Morino, K., Dong, J., Wang-Fischer, Y., Cline, G. W., Romanelli, A. J., Rossbacher, J. C., Moore, I. K., Regittnig, W., Munoz, D. S., et al. (2007) · Diabetes · doi:10.2337/db06-1206 · Cited by 233
Novel ? ? 3-derived local mediators in anti-inflammation and resolution
NSERHAN, C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.09.002 · Cited by 181 · cited 1×
“The effects of n-3 LC-PUFAs and their active metabolites (17,18) are mediated by peroxisome proliferatoractivated receptors (PPAR), with PPAR- and PPAR- (- ) being the main targets (14,16), although PPAR- , liver X receptor- , hepatic nuclear factor-4, sterol regulatory element binding protein-1c (SREBP-1c) and carboh…”
BackgroundDiacylglycerol – when is it an intracellular messenger?
Wakelam, M. J. O. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00123-4 · Cited by 176
Villena, J. A., Viollet, B., Andreelli, F., Kahn, A., Vaulont, S., & Sul, H. S. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2242 · Cited by 161 · cited 2×
“In accordance with the previous study (49), plasma adiponectin levels tended to be reduced in AMPK 2 / mice.”
ResultSelf-citationSchmitz-Peiffer, C., & Biden, T. J. (2008) · Diabetes · doi:10.2337/db07-1769 · Cited by 158
Kuda, O., Jelenik, T., Jilkova, Z., Flachs, P., Rossmeisl, M., Hensler, M., Kazdova, L., Ogston, N., Baranowski, M., Gorski, J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1305-z · Cited by 142 · cited 3×
“Previous animal studies demonstrated that n-3 LC-PUFAs could counteract the development of both hepatic steatosis (8,18,36,37) and hepatic insulin resistance (8,9,16), while suppressing lipogenesis and augmenting lipid catabolism in the liver (8,13,19,21).”
BackgroundMethodSelf-citationKopecky, J., Rossmeisl, M., Flachs, P., Kuda, O., Brauner, P., Jilkova, Z., Stankova, B., Tvrzicka, E., & Bryhn, M. (2009) · Proceedings of the Nutrition Society · doi:10.1017/s0029665109990231 · Cited by 137 · cited 2×
“Previous studies reported contradictory results, showing either 1) activation of AMPK in rat liver (22) and murine adipose tissue (24) or 2) no changes in AMPK activity in the liver, skeletal muscle, and heart of mice (43) in response to dietary n-3 LC-PUFAs.”
BackgroundResultSelf-citationDietary polyunsaturated fatty acids enhance hepatic AMP-activated protein kinase activity in rats
Suchánková, G., Tekle, M., Saha, A. K., Ruderman, N. B., Clarke, S. D., & Gettys, T. W. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.114 · Cited by 129 · cited 2×
“Previous studies reported contradictory results, showing either 1) activation of AMPK in rat liver (22) and murine adipose tissue (24) or 2) no changes in AMPK activity in the liver, skeletal muscle, and heart of mice (43) in response to dietary n-3 LC-PUFAs.”
BackgroundResultEffect of Synthetic Dietary Triglycerides: A Novel Research Paradigm for Nutrigenomics
Sanderson, L. M., de Groot, P. J., Hooiveld, G. J. E. J., Koppen, A., Kalkhoven, E., Müller, M., & Kersten, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001681 · Cited by 126
Jucker, B. M., Cline, G. W., Barucci, N., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.1.134 · Cited by 119
Park, S.-Y., Kim, H.-J., Wang, S., Higashimori, T., Dong, J., Kim, Y.-J., Cline, G., Li, H., Prentki, M., Shulman, G. I., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00251.2004 · Cited by 108
Teran-Garcia, M., Adamson, A. W., Yu, G., Rufo, C., Suchankova, G., Dreesen, T. D., Tekle, M., Clarke, S. D., & Gettys, T. W. (2007) · Biochemical Journal · doi:10.1042/bj20061722 · Cited by 104 · cited 2×
“Previous animal studies demonstrated that n-3 LC-PUFAs could counteract the development of both hepatic steatosis (8,18,36,37) and hepatic insulin resistance (8,9,16), while suppressing lipogenesis and augmenting lipid catabolism in the liver (8,13,19,21).”
BackgroundMetabolic effects of fish-oil supplementation in patients with impaired glucose tolerance
Fasching, P., Ratheiser, K., Waldhäusl, W., Rohac, M., Osterrode, W., Nowotny, P., & Vierhapper, H. (1991) · Diabetes · doi:10.2337/diab.40.5.583 · Cited by 102 · cited 1×
“However, in diabetic patients, n-3 LC-PUFAs appear to have little effect on glycemic control (3,11,12).”
BackgroundAnalysis of the Role of the AMP-Activated Protein Kinase in the Response to Cellular Stress
Hardie, D. G., Salt, I. P., & Davies, S. P. (2003) · Stress Response · doi:10.1385/1-59259-054-3:63 · Cited by 88 · cited 1×
“Livers were collected by freezeclamping, AMPK was immunoprecipitated from tissue extracts, and the activity was assayed using a peptide substrate (32); see the online appendix.”
MethodPrpic, V., Watson, P. M., Frampton, I. C., Sabol, M. A., Jezek, G. E., & Gettys, T. W. (2003) · Endocrinology · doi:10.1210/en.2002-220835 · Cited by 82
Kajikawa, S., Harada, T., Kawashima, A., Imada, K., & Mizuguchi, K. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.02.004 · Cited by 77 · cited 1×
“Previous animal studies demonstrated that n-3 LC-PUFAs could counteract the development of both hepatic steatosis (8,18,36,37) and hepatic insulin resistance (8,9,16), while suppressing lipogenesis and augmenting lipid catabolism in the liver (8,13,19,21).”
BackgroundGabler, N. K., Radcliffe, J. S., Spencer, J. D., Webel, D. M., & Spurlock, M. E. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.11.009 · Cited by 67 · cited 1×
“It has been demonstrated that n-3 LC-PUFAs enhanced AMP-activated protein kinase (AMPK) activity in the liver (22), intestine (23), and adipose tissue (18,24).”
Backgroundvan Schothorst, E. M., Flachs, P., Franssen-van Hal, N. L., Kuda, O., Bunschoten, A., Molthoff, J., Vink, C., Hooiveld, G. J., Kopecky, J., & Keijer, J. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-110 · Cited by 64 · cited 1×
“The hypolipidemic and antiobesity effects of n-3 LCPUFAs depend on both the suppression of lipogenesis and the increase in fatty acid oxidation in several tissues, including the liver (13,14), adipose tissue (6), and intestine (15).”
BackgroundSelf-citationPolak, J., Kováčová, Z., Jaček, M., Klimčáková, E., Kováčiková, M., Šiklová, M., Kuda, O., Šebela, M., Samcová, E., & Štich, V. (2007) · Clinical Science · doi:10.1042/cs20060296 · Cited by 63 · cited 1×
“Total adiponectin levels and adiponectin multimeric complexes were determined using Western blotting (31).”
MethodSelf-citationSalati, L. M., & Clarke, S. D. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90451-0 · Cited by 50 · cited 1×
“In accordance with the involvement of AMPK 2 in various effects of n-3 LC-PUFAs, our results document activation of AMPK 2 (but not AMPK 1) in the liver of mice by long-term n-3 LC-PUFA treatment, in the absence of significant changes in either the AMP to ATP ratio assessed in whole liver extracts [not shown and ref (…”
BackgroundEffect of exercise duration on ceramide metabolism in the rat heart
Baranowski, M., Zabielski, P., Blachnio, A., & Gorski, J. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01755.x · Cited by 45
Self-citationRoemen, T. H. M., & Vusse, G. J. (1985) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)82031-9 · Cited by 38
Polyunsaturated fatty acids do not activate AMP-activated protein kinase in mouse tissues
Dobrzyń, A., Dobrzyń, P., Miyazaki, M., & Ntambi, J. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.026 · Cited by 33 · cited 1×
“Previous studies reported contradictory results, showing either 1) activation of AMPK in rat liver (22) and murine adipose tissue (24) or 2) no changes in AMPK activity in the liver, skeletal muscle, and heart of mice (43) in response to dietary n-3 LC-PUFAs.”
ResultMetabolic Effects of Omega‐3 Fatty Acids in Type 2 (Non‐Insulin‐Dependent) Diabetic Patients
PELIKÁNOVÁ, T., KOHOUT, M., VÁLEK, J., KAZDOVÁ, L., & BAŠE, J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35716.x · Cited by 33
Ohira, M., Miyashita, Y., Murano, T., Watanabe, F., & Shirai, K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.024 · Cited by 31
Cited by
AMPK, insulin resistance, and the metabolic syndrome
Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67227 · Cited by 873
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
Rossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038834 · Cited by 230
Self-citationLipid signaling in adipose tissue: Connecting inflammation & metabolism
Masoodi, M., Kuda, O., Rossmeisl, M., Flachs, P., & Kopecky, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.023 · Cited by 221
Self-citationOmega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome
Martínez-Fernández, L., Laiglesia, L. M., Huerta, A. E., Martínez, J. A., & Moreno-Aliaga, M. J. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.07.003 · Cited by 212
Metadata
- Authors
- Jelenik, T., Rossmeisl, M., Kuda, O., Jilkova, Z. M., Medrikova, D., Kus, V., Hensler, M., Janovska, P., Miksik, I., Baranowski, M., Gorski, J., Hébrard, S., Jensen, T. E., Flachs, P., Hawley, S., Viollet, B., & Kopecky, J.
- Affiliations
- Department of Adipose Tissue Biology and the
- Department of Analysis of Biologically Important Compounds, Institute of Physiology of the Academy of Sciences of the Czech Republic, v.v.i., Prague, Czech Republic;
- Medical University of Białystok (PL)
- Department of Physiology, Medical University of Bialystok, Poland;
- Centre National de la Recherche Scientifique (FR)
- University of Copenhagen (DK)
- University of Dundee (GB)
- Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France;
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-06
- Volume
- 59
- Issue
- 11
- Pages
- 2737-2746
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963531
- OpenAlex
- W2136917561
- Cited by
- 88
- References
- 55
- Citations by year
- 2026: 3 · 2024: 2 · 2023: 4 · 2021: 5 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 9 · 2015: 10 · 2014: 14 · 2013: 6 · 2012: 9
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ASEP (submittedVersion, public-domain)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- AMPK, AMPKα2, n-3 long-chain polyunsaturated fatty acids, hepatic insulin sensitivity, insulin resistance, hepatic steatosis, adiponectin, diacylglycerol, dyslipidemia, obesity, high-fat diet, triglycerides, free fatty acids, hepatic lipid metabolism
- MeSH terms
- Animals, Dietary Fats, Fatty Acids, Unsaturated, Hyperinsulinism, Insulin Resistance, Liver, Glucose Clamp Technique, Fatty Acids, Omega-3, Mice, Knockout, Diet, Fat-Restricted, Cell Culture Techniques, Protein Subunits, Hepatocytes, Metabolic Syndrome, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.